To determine if NPC cells could be sensitized by co-inhibition of PLK1 and Aurora kinases, the respective inhibitors were used at relative low concentrations that did not elicit a significant response on their own. The gene discussed is PLK1; the disease is nasopharyngeal carcinoma.